Author:
Taha Sheena,King Samantha,Atif Sara,Bate Eliza
Abstract
Abstract
Background
Harm reduction (HR) is a critical response to the pronounced toxicity deaths being experienced in Canada. HR providers report many benefits of their jobs, but also encounter chronic stress from structural inequities and exposure to trauma and death. This research study sought to quantify the emotional toll the toxicity emergency placed on HR providers (Cycle One; 2019). Study objectives were later expanded to determine the impact of the ongoing toxicity as well as the pandemic’s impact on well-being (Cycle Two; 2021).
Methods
Standardized measures of job satisfaction, burnout, secondary traumatic stress, and vulnerability to grief were used in an online national survey. Open-ended questions addressed resources and supports. HR partners across Canada validated the findings and contributed to alternative interpretations and implications.
Results
651 respondents in Cycle One and 1,360 in Cycle Two reported moderately high levels of job satisfaction; they reported finding great meaning in their work. Yet, mean levels of burnout and secondary traumatic stress were moderate, with the latter significantly increasing in Cycle Two. Reported vulnerability to grief was moderate but increased significantly during COVID. When available, supports lacked the quality necessary to respond to the complexities of HR workers’ experiences, or an insufficient number of sessions were covered through benefits. Respondents shared that their professional quality of life was affected more by policy failures and gaps in the healthcare system than it was by the demands of their jobs.
Conclusion
Both the benefits and the strain of providing harm reduction services cannot be underestimated. For HR providers, these impacts are compounded by the drug toxicity emergency, making the service gaps experienced by them all the more critical to address. Implications highlight the need for integration of HR into the healthcare system, sustainable and reliable funding, sufficient counselling supports, and equitable staffing models. Support for this essential workforce is critical to ensuring the well-being of themselves, the individuals they serve, and the health of the broader healthcare system.
Funder
Canadian Centre on Substance Use and Addiction, Canada
Publisher
Springer Science and Business Media LLC
Reference65 articles.
1. Health Canada. Opioid symposium: What we heard report. 2019. https://publications.gc.ca/collections/collection_2019/sc-hc/H14-306-2019-eng.pdf. Accessed 26 September 2023.
2. Special Advisory Committee on the Epidemic of Opioid Drug toxicitys. Opioid- and stimulant-related harms. Public Health Agency of Canada. 2021. https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants. Accessed 26 September 2023.
3. Alberta Community Council on HIV. A Community Based Report on Alberta’s Supervised Consumption Service Effectiveness. HarmReduction.eu. 2019. https://harmreduction.eu/resources/dcr/a-community-based-report-on-albertas-supervised-consumption-service-effectiveness/. Accessed 26 September 2023.
4. Irvine MA, Kuo M, Buxton JA, Balshaw R, Otterstatter M, Macdougall L, et al. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic. Addiction. 2019;114:9:1602–13.
5. Kerr T, Mitra S, Kennedy MC, McNeil R. Supervised injection facilities in Canada: past, present, and future. Harm Reduct J. 2017;14:1:28.